Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Fintech PR

From Instagram to High Times: Unpacking the Power of Vast User Networks

Published

on

from-instagram-to-high-times:-unpacking-the-power-of-vast-user-networks

NetworkNewsWire Editorial Coverage

NEW YORK, Sept. 19, 2023 /PRNewswire/ — In the business world, one of the cardinal reasons for mergers and acquisitions (M&As) is the potential for synergistic growth. Successful companies usually measure this in terms of revenue streams, market share and product offerings. However, in the age of digital technology and globalization, a significant facet of growth potential is often found a company’s core customer base and digital reputation. Lucy Scientific Discovery (NASDAQ: LSDI) (Profile) is astutely following this road map utilized by hugely successful corporations by uniquely leveraging user bases to rapidly amplify shareholder value. This well-established, albeit counterintuitive, M&A strategy has been utilized by several major companies including Meta Platforms Inc. (NASDAQ: META), Microsoft Corp (NASDAQ: MSFT), Amazon.com Inc. (NASDAQ: AMZN) and Apple Inc. (NASDAQ: AAPL) with the unconventional process producing results that vastly exceeded expected typical M&A metrics.

  • Strategic acquisitions prove that harnessing the power of niche user bases can lead to parabolic growth.
  • Lucy Scientific Discovery has recognized the value of uniquely leveraging user bases to rapidly amplify shareholder value.
  • Earlier this year the company entered into a share purchase agreement to acquire the total IP of High Times.
  • Most recently, Lucy announced the signing of an amalgamation agreement to acquire BlueSky Wellness, a move that expands its footprint into the growing global wellness category.

Click here to view the custom infographic of the Lucy Scientific Discovery editorial.

Headline Makers

Meta’s strategic acquisition of Instagram in 2012 for $1 billion was less than one week after the roll out of its Android app, when it accumulated more than a million downloads in a day. Then, in 2014, Meta’s radar locked onto WhatsApp, boasting more than 200 million users. The acquisition price was steep at $19 billion, but the value wasn’t just in the application’s functionality — it was in its colossal global user base.

Microsoft deployed a similar aggressive acquisition strategy of identifying opportunities to diversify and strengthen position and market share by tapping into vast niche user networks. In 2011, Microsoft’s $8.5 billion acquisition of Skype, a platform with more than 660 million global users, became a classic example of how the tech giant was looking beyond just software integration to a global platform integration strategy. Then, in 2016, Microsoft made headlines again by acquiring LinkedIn for $26.2 billion. LinkedIn, unlike other social media platforms, was the first mover and dominant in the professional networking space.

A Golden Opportunity

These moves by Meta and Microsoft underscore a clear strategy: Harnessing the power of niche user bases can lead to parabolic growth.

Enter Lucy Scientific Discovery (NASDAQ: LSDI), a company that has recognized the value in this counterintuitive approach. Lucy’s recent share purchase agreement to acquire the total intellectual property (IP) of High Times shows that the company truly understands the immense value of a large, loyal audience. In an all-stock transaction, the acquisition provides a stream of high-margin licensing and royalty income from the well-regarded High Times. More importantly, with its massive following, the High Times acquisition offers a golden opportunity for Lucy Scientific Discovery to introduce and distribute its products to a captive, engaged audience, while benefitting from significant early-stage revenue.

On closing, Lucy will acquire all the brand rights and fully intends to monetize the broad-based IP through both current and future royalty agreements. Lucy also plans to extend and enhance the existing domestic and international licensing arrangements currently held by High Times, including consumer products and merchandise. The company expects to preserve the core essence of the High Times brands and its followers while simultaneously expanding the follower base and pursuing new avenues of growth and development.

“Lucy expects this acquisition to drive high margin revenue quickly and sustainably,” said Richard Nanula, Lucy Scientific Discovery CEO and executive chair. “This is a great opportunity to grow the market presence of the nearly 50-year-old High Times brand globally through licensing and online distribution. We are confident that this opportunity can add significant value for our shareholders.”

Advertisement

Lucy Scientific Discovery’s move also appears to be a strategic play to leverage an established niche audience for direct product sales, reputation and influence — just like Meta and Microsoft purchased platforms with vast niche user bases to expand their influence,

The message is clear: Niche user bases are invaluable, as they offer immediate access to engaged consumers, a chance for cross-selling, and opportunities for expansion and diversification. As these cases illustrate, sometimes the most compelling asset isn’t a product, patent, or technology—it’s the people using them. In the digital age, where user engagement is currency, companies that recognize and act upon this fact will often find themselves in an enviable position of growth and influence.

Testament to Shareholder Commitment

High Times isn’t the only M&A move that Lucy Discovery has made. In another all-stock deal, the company continued its savvy strategy with the amalgamation agreement to acquire BlueSky Wellness, a move that quickly expands Lucy’s footprint into the growing global wellness category on closing. BlueSky Wellness built an impressive a portfolio of plant-based wellness brands that have generated more than $20 million in each of its last two years that complement High Times’ products and platforms and should positively impact the bottom line of Lucy Scientific Discovery.

“The addition of the BlueSky portfolio and its team will allow us to capitalize on revenue opportunities,” said Nanula. “Coupled with our High Times acquisition, this will strategically position us for substantial near- and long-term growth. The recent announcements are a testament to our commitment to expand and grow our business, adding revenue that diversifies our company and should deliver significant value to our Lucy Scientific shareholders.”

BlueSky is led by a team of seasoned CPG executives with experience at Fortune 500 companies, including PepsiCo, SC Johnson, General Mills and Robert Half. They have built and exited a number of successful companies over the last decade. The acquisition brings a unique suite of marketing capabilities, brand-building prowess and a highly skilled team with extensive relationships to the Lucy Discovery table.

Major League Acquisitions

Meta Platforms Inc. (NASDAQ: META) builds technologies that help people connect, find communities, and grow businesses. When Facebook launched in 2004, it changed the way people connect. Apps such as Messenger, Instagram and WhatsApp further empowered billions around the world. Now, Meta is moving beyond 2D screens toward immersive experiences like augmented and virtual reality to help build the next evolution in social technology. The company continues to make key acquisitions that support its strategic business plan.

Microsoft Corp. (NASDAQ: MSFT) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more. The company has a long history of acquisitions, with more than a hundred acquisitions since 1994.

Amazon.com Inc. (NASDAQ: AMZN) is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Amazon strives to be  the most customer-centric company, best employer, and safest place to work in the world. The company has a rich history of acquisitions; most recently the company added One Medical to its roster of strategic additions.

Advertisement

Apple Inc. (NASDAQ: AAPL) designs, manufactures, and markets smartphones, tablets, personal computers and wearable devices. The company offers software applications and related services, accessories, and third-party digital content. Apple’s product portfolio includes iPhone, iPad, Mac, iPod, Apple Watch and Apple TV. Earlier this year, the company acquired Mira, a Los Angeles-based AR startup that makes headsets for other companies as well as the U.S. military. Apple typically doesn’t discuss acquisitions, but it did confirm the acquisition and issued the statement it traditionally provides when buying a company: “Apple buys smaller technology companies from time to time, and we generally do not discuss our purpose or plans.”

Lucy Scientific Discovery’s last few weeks action of unconventional strategic acquisitions is a clear indication that the company fully recognizes the inherent value of large and loyal user networks. More importantly than just the inherent value of these networks, the company is fast tracking the integration and expansion of these networks and maximizing revenue streams that will ultimately impact shareholder value. Utilizing part of an unconventional playbook from some major league successful acquisitions, Lucy Scientific Discovery is intent on writing a new chapter of success aimed at benefiting all stakeholders.

For more information about Lucy Scientific Discovery Inc., please visit Lucy Scientific Discovery.

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled recognition and brand awareness. NNW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.NetworkNewsWire.com.

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: https://www.NetworkNewsWire.com/Disclaimer.

NetworkNewsWire is powered by IBN.

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

Advertisement

NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.

Contact:

NetworkNewsWire
New York, NY
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

 

View original content:https://www.prnewswire.co.uk/news-releases/from-instagram-to-high-times-unpacking-the-power-of-vast-user-networks-301931958.html

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

NYSE Content advisory: Pre-market update for March 14, 2025

Published

on

NEW YORK, March 14, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins.

  

Alison Kosik delivers the pre-market update on March 14th

  • Investors welcomed a cooler-than-expected Producer Price Index reading for the month of February as tariff talk continues out of Washington D.C.
  • Attention shifts to the Federal Reserve decisions coming next week as inflation data suggests the rate of inflation growth could be slowing.
  • S&P 500 looks to rebound after ending yesterday in correction territory, which is a decline of at least 10% from a recent high.

Watch NYSE TV Live every weekday 9:00-10:00am ET 

NYSE Logo

Video – https://mma.prnewswire.com/media/2641945/NYSE_March_14_2025_Market_Update.mp4
Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update-for-march-14-2025-302401916.html

Continue Reading

Fintech PR

Curve Secures £37M Investment led by Hanaco Ventures as the Company approaches profitability and prepares to Launch Curve Pay in 2025

Published

on

curve-secures-37m-investment-led-by-hanaco-ventures-as-the-company-approaches-profitability-and-prepares-to-launch-curve-pay-in-2025

2025 is shaping up to be a milestone year for Curve as it forecasts reaching profitability, expands its product offerings, and prepares to introduce its challenger to Apple Pay and Google Wallet—Curve Pay.

LONDON, March 14, 2025 /PRNewswire/ — Curve, the digital wallet that saves you money, announced today it has secured a £37M investment led by Hanaco Ventures, with participation of existing shareholders such as Fuel Ventures, IDC, Outward VC and Lord Stanley Fink. The funding will support Curve’s ambitious plans for 2025, including industry-first product launches and a series of customer-driven enhancements set to redefine how consumers manage their money in the future. Crucially, this capital injection strengthens Curve’s financial position, accelerating its path to profitability while continuing to innovate and scale.

With regulatory changes forcing behemoths like Apple to open their NFC technology and digital wallet adoption surging across the UK and Europe, combined with banks actively looking to introduce their own Wallet solutions, the market is primed for intense competition in digital wallets. As people seek more options and greater flexibility in how they control their finances, Curve, as the established champion for consumer choice, is developing an offering which benefits both consumers and banks simultaneously. The investment from Hanaco will further enable Curve to capitalize on these market shifts — precipitated by consumer demand for more choice — expanding its market presence and partnerships, strengthening its infrastructure, and enhancing customer experiences.

“This latest investment reflects the confidence in Curve’s vision to redefine the digital wallet space,” said Shachar Bialick, Founder & CEO of Curve. “The Wallet Wars are here, and the only available solutions for customers to date are simple wallets which do nothing more than let you pay with your card. Curve is the only wallet that adds superpowers to your money; avoid Fx fees from any linked card, split old purchases into installments, earn cashback on top of any card and more. We see issuers looking to enter the market, and networks introducing innovative products such as Visa Flex and MasterCard One Credentials. This investment would allow us to invest further in our customer experience, bring new partnerships, and accelerate our path to profitability.” 

“Curve reimagined the digital wallet delivering a one-of-a-kind financial experience that simplifies and supercharges how you pay and manage your money – all without changing your bank,” said Tomer Jacob at Hanaco. “The Curve team has proven to be resilient and innovative, and we are excited to support Curve as it continues to grow, bringing more choice and flexibility to the digital wallet market, and to its millions of users.”

Curve has consistently delivered a digital wallet designed to provide greater control and flexibility to its growing global customer base of what is currently over six million users. Starting with the Curve Card — the one card to rule them all. While benefits like stacking rewards, real-time spending insights, and avoiding foreign exchange fees, empowers customers to save money and make informed financial decisions, innovations such as Go Back in Time® allow them to retroactively move transactions between cards, and manage their cashflow better, avoid debt etc. 

Curve also offers a number of unique borrowing features and benefits. Curve ReFI enables customers to instantly transfer balances from one card to another, preventing unnecessary interest accrual, late payment fees, and overdrafts. Another recent invention, Curve Flex enables customers to split any past or future purchases into manageable instalments, wherever they shop. Further strengthening its commitment to financial empowerment, Curve has this week partnered with Infact to introduce real-time credit reporting for Curve Flex customers. 

A key milestone for the company will be the upcoming launch of Curve Pay, a digital wallet alternative for Android and iOS users. 

About Curve

Curve is a pioneering digital wallet that goes beyond simply storing your cards digitally. Unlike other digital wallets, Curve actively works to save you money and enhance every payment you make. Through its cutting-edge wallet technology, Curve will help you avoid hidden foreign transaction fees from any linked card, allows you to switch payment cards even after purchase, and lets you earn rewards on top of your existing card benefits.

Advertisement

The Curve Wallet sits at the heart of this technology, bringing all your cards and other payment sources into one secure platform while adding unique money-saving features. Whether you’re shopping online, in-store, or abroad, Curve gets the most value for your money. Authorised and regulated in the UK, EEA, and US, Curve has amassed more than 6 million customers globally, and processes billions in payments annually while continuing to innovate in digital finance.

View original content:https://www.prnewswire.co.uk/news-releases/curve-secures-37m-investment-led-by-hanaco-ventures-as-the-company-approaches-profitability-and-prepares-to-launch-curve-pay-in-2025-302401910.html

Continue Reading

Fintech PR

Azurity Pharmaceuticals Completes Acquisition of Covis Pharma

Published

on

azurity-pharmaceuticals-completes-acquisition-of-covis-pharma

WOBURN, Mass., March 14, 2025 /PRNewswire/ — Azurity Pharmaceuticals (“Azurity”) announced today the successful completion of its acquisition of Covis Group S.à r.l. (“Covis”) from existing investors. With this acquisition, Covis is now a wholly-owned subsidiary of Azurity.     

This strategic acquisition reinforces Azurity’s leadership in branded pharmaceuticals, harnessing the complementary strengths of both companies across multiple complex dosage forms and therapeutic areas. By combining expertise and resources, Azurity strengthens its ability to deliver medicines to overlooked patients on a global scale.

Strategic Benefits of the Acquisition:

  • Expanded Therapeutic Portfolio – The integration of Covis’ product portfolio and pipeline enhances Azurity’s offerings across ten complex dosage forms and nine key therapeutic areas, including cardiovascular, respiratory, central nervous system, endocrinology, gastrointestinal, hematology, immunology, anti-infectives, and oncology.
  • Global Footprint – The acquisition strengthens Azurity’s global footprint, expanding its commercial presence to over 50 countries and enabling greater patient accessibility to life-changing treatments. Azurity and its subsidiaries will employ more than 800 colleagues across North America, Europe and Asia. 
  • Key Biopharma Partner of Choice – The combined company is positioned to be a key partner for global life sciences companies looking to develop and commercialize their products, providing partners access to its deep development capabilities and global commercial infrastructure. 
  • Accelerated Innovation – By combining expertise and resources, Azurity is positioned to advance innovative treatments furthering Azurity’s mission to serve overlooked patients using a unique and accelerated development process – enabling scale and velocity.
  • Next-Gen Commercial Model – The integrated company portfolio will benefit from Azurity’s highly efficient and effective commercial model, combining data, analytics, and AI-driven digital capabilities to drive stakeholder engagement using an optimized omnichannel marketing approach.

“We are excited to welcome Covis Pharma to Azurity,” said Ronald Scarboro, CEO of Azurity. “The efforts of colleagues at both companies, their devotion to overlooked patients, and our culture of execution have brought us together to build this unique, highly differentiated pharmaceutical company. I look forward to all that we will accomplish as we grow globally and embrace new opportunities, driven by our purpose.”

“I am delighted that Azurity recognized the accomplishments and potential of Covis, and am thankful for the tireless efforts of Covis colleagues in support of patients that benefit from the company’s products,” said Rajiv De Silva, Chairman of the Board of Covis. “I am confident that the two companies will be able to untap each other’s highly complementary capabilities to accelerate development and commercialization of necessary medicines to underserved patients.”

“QHP Capital is proud to support Azurity in this acquisition, which aligns with our commitment to investing in life sciences and healthcare innovations,” said Jeff Edwards, Partner at QHP Capital, the majority owner of Azurity. “It has been our privilege to support and enable Azurity from a small, limited product, US-only company at the start of our investment in 2018 to the global, large, diversified portfolio, high-growth company it is today. We are committed to further enabling Azurity for the significant growth its team is well positioned to execute.”

Goldman Sachs served as financial advisor and Eversheds Sutherland and White & Case served as legal advisors to Azurity. Guggenheim Securities served as financial advisor to Covis and Reed Smith and A&O Shearman served as legal advisors to Covis.     

About Azurity Pharmaceuticals:
Azurity Pharmaceuticals is a privately held company committed to delivering innovative, high-quality medicines for overlooked patients. Azurity’s global footprint is over 50 countries, with a diversified portfolio of 30+ marketed brands spanning ten dosage forms and nine key therapeutic areas. Powered by its Next-Gen Commercial Model, Azurity leverages data, analytics, and AI-driven digital tools to enhance market reach and stakeholder engagement. For more information, visit www.azurity.com.

About QHP Capital: 
QHP Capital is an investor in technology and services companies in the life sciences, medical technology, and healthcare sectors. QHP has built an investment platform to provide strategic capital and industry expertise in partnership with strong management teams. The investment team consists of seasoned investment and operational professionals with significant investment experience and deep life science, medical technology, and healthcare expertise. QHP benefits from an extensive network of industry experts that assist in identifying, analyzing, and growing QHP’s portfolio companies. For more information, please visit www.qhpcapital.com.

Disclosure notice: Azurity and QHP undertake no obligation to update or revise any forward-looking statements contained in this release as a result of new information, future events, or evolving circumstances.  

Logo – https://mma.prnewswire.com/media/1435351/Azurity_r_rgb_Logo.jpg

Advertisement

Cision View original content:https://www.prnewswire.co.uk/news-releases/azurity-pharmaceuticals-completes-acquisition-of-covis-pharma-302401906.html

Continue Reading
Advertisement
Advertisement European Gaming Congress 2024

Latest news

Trending